C12P 21 - Preparation of peptides or proteins

Patents for C12P 21 - Preparation of peptides or proteins (112,499)
12/2002
12/19/2002	US20020192760 Nucleotide sequences coding membrane protein for use the diagnosis and treatment of asthma, parkinson's, heart defects, hypotension, urogenital disorders
12/19/2002	US20020192758 C3b/C4b complement receptor-like molecules and uses thereof
12/19/2002	US20020192757 Small and intermediate conductance, calcium-activated potassium channels and uses thereof
12/19/2002	US20020192754 Generation of preferential serine proteases; obtain genetically engineered prokaryotic cell, transform with gene expressing serine proteases, recover serine proteases
12/19/2002	US20020192752 Compositions and methods for the treatment of immune related diseases
12/19/2002	US20020192743 Method for the expression of proteins in in vitro translation systems with coexpression of folding helper proteins
12/19/2002	US20020192729 Apoptosis protein for use in the diagnosis and treatment of cell proliferative disorders
12/19/2002	US20020192706 Nucleotide sequences coding polypeptides for use treatment of cell proliferation disorders
12/19/2002	US20020192682 Polynucleotides and polypeptides of the IFNalpha-2 gene
12/19/2002	US20020192668 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/19/2002	US20020192659 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/19/2002	US20020192643 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferation or inflammatory disorders
12/19/2002	US20020192639 HCV antigen/antibody combination assay
12/19/2002	US20020192237 Polypeptides containing polymorphisms of the repeated regions of pertactin in bordetella pertussis, bordetella parapertussis, and bordetella bronchiseptica, their use in diagnostics, and in immunogenic compositions
12/19/2002	US20020192236 Culture product; purification of cytotoxin; gastrointestinal disorders; antiulcer agents
12/19/2002	US20020192232 Methods and compositions for impairing multiplication of HIV-1
12/19/2002	US20020192228 Protein markers for lung cancer and use thereof
12/19/2002	US20020192226 Production of a parvovirus vaccine in plants as viral coat protein fusions
12/19/2002	US20020192220 Compositions and methods relating to colon specific genes and proteins
12/19/2002	US20020192213 Monoclonal antibodies specific to VEGF receptors and uses thereof
12/19/2002	US20020192209 Methods and compositions for inhibiting neoplastic cell growth
12/19/2002	US20020192193 Antigen presenting cells, a process for preparing the same and their use as cellular vaccines
12/19/2002	US20020192192 Antigen presenting cells, a process for preparing the same and their use as cellular vaccines
12/19/2002	CA2450285A1 Human monoclonal antibodies to epidermal growth factor receptor (egfr)
12/19/2002	CA2450022A1 Method of testing drug for treating or preventing diseases such as hyperlipemia
12/19/2002	CA2450019A1 Production of proteins in plants
12/19/2002	CA2449649A1 A g-protein coupled receptor and uses therefor
12/19/2002	CA2449602A1 Ns4 nucleic acids and polypeptides and methods of use for the treatment of body weight disorders
12/19/2002	CA2449591A1 Brain expressed gene and protein associated with bipolar disorder
12/19/2002	CA2449440A1 Structural and cytoskeleton-associated proteins
12/19/2002	CA2449272A1 Intracellular signaling molecules
12/19/2002	CA2448432A1 Purification of human serum albumin
12/19/2002	CA2448289A1 Method of constructing host and method of producing heterologous protein
12/19/2002	CA2447791A1 Methods of culturing animal cells and polypeptide production in animal cells
12/19/2002	CA2447658A1 Nucleic acid constructs useful for glucose regulated production of human insulin in somatic cell lines
12/19/2002	CA2445898A1 Photoimmunotherapies for cancer using photosensitizer immunoconjugates and combination therapies
12/19/2002	CA2418808A1 Human-type anti-blood coagulation factor viii antibody
12/18/2002	EP1266965A2 Recombinant antibodies for human therapy
12/18/2002	EP1266961A1 Kidney repairing factor
12/18/2002	EP1266025A1 Protein scaffolds for antibody mimics and other binding proteins
12/18/2002	EP1266020A2 Production of foreign polypeptides in plants as viral coat protein fusions
12/18/2002	EP1266014A2 Multifunctional polypeptides comprising a binding site to an epitope of the nkg2d receptor complex
12/18/2002	EP1266012A2 Proteases
12/18/2002	EP1266011A1 Fungal transcriptional activator useful in methods for producing polypeptides
12/18/2002	EP1266008A2 Acute neuronal induced calcium binding protein type 1 ligand
12/18/2002	EP1266007A1 Human survivin interacting protein 1 (sip-1)
12/18/2002	EP1266006A2 Production of recombinant blood clotting factors in human cell lines
12/18/2002	EP1266003A2 Kcnb: a potassium channel protein
12/18/2002	EP1266002A2 Il-17 receptor like molecules and uses thereof
12/18/2002	EP1266001A2 Human transcription factors
12/18/2002	EP1266000A1 Chordin-like-2 molecules and uses thereof
12/18/2002	EP1265999A2 Human schizophrenia gene
12/18/2002	EP1265990A2 Renilla reniformis fluorescent proteins, nucleic acids encoding the fluorescent proteins and the use thereof in diagnostics, high throughput screening and novelty items
12/18/2002	EP1265928A1 Ultra high affinity neutralizing antibodies
12/18/2002	EP1265924A2 Il-17 receptor like molecules and uses thereof
12/18/2002	EP1265919A2 G-protein associated molecules
12/18/2002	EP1265918A1 Human immune response proteins
12/18/2002	EP1265915A2 Novel compounds
12/18/2002	EP1265913A1 Characterization of grp94-ligand interactions and purification, screening, and therapeutic methods relating thereto
12/18/2002	EP1265912A1 Mass1 gene, a target for anticonvulsant drug development
12/18/2002	EP1265910A2 Nucleic acids, proteins, and antibodies
12/18/2002	EP1265708A1 Microreactor
12/18/2002	EP0904296B1 Monoclonal antibody that detects apoptotic antigen
12/18/2002	EP0866803B1 Transferrin receptor protein of moraxella
12/18/2002	EP0789583B1 Methods and kits using macrophage stimulating protein
12/18/2002	EP0726944B1 Glycosylated and non-glycosylated bactericidal/permeability increasing proteins, and methods for producing same
12/18/2002	EP0668930B1 A method of identifying ligands and antagonists of ligands
12/18/2002	EP0662150B1 Maspin, a novel serpin with tumor suppressing activity
12/18/2002	EP0641385B1 Development of dna probes and immunological reagents of human tumor associated antigens
12/18/2002	EP0555370B1 Methods and applications for efficient genetic suppressor elements
12/18/2002	EP0551440B1 Design of bioactive peptides based on immunoglobulin structure
12/18/2002	EP0521996B1 Catalytic antibody components
12/18/2002	CN1385533A Process for preparing recombinant human liver cell grouth factor
12/18/2002	CN1385526A Precursor gene of ink chest wasp aptoxin bematolysis peptide, its coded polypeptide and preparation process thereof
12/18/2002	CN1385441A Novel human lymphokine, its coding sequence and use
12/17/2002	US6495742 Stress tolerant plants; genetic engineering
12/17/2002	US6495736 Compositions and methods for increasing bone mineralization
12/17/2002	US6495735 Transgenic non-human mammals expressing DNA sequences encoding homologous complement restriction factors of a discordant mammalian species
12/17/2002	US6495666 Polypeptide composing human chimeric antibody
12/17/2002	US6495662 Bioactive peptides and peptide derivatives of parathyroid hormone (PTH) and parathyroid hormone-related peptide (PTHrP)
12/17/2002	US6495519 Interleukin-1 β converting enzyme like apoptosis protease-3 and 4
12/17/2002	US6495516 Method for killing gram-negative bacteria with biologically active peptides from functional domains of bacterial/permeability-increasing protein
12/17/2002	US6495360 Increasing production yield of viruses, viral proteins, and other related biological materials through enhanced control and stabilization of protein production via stress proteins; permissive eukaryotic cell lines
12/17/2002	US6495347 Determining if fusion protein stimulates a th1-like response in cell sample; fusion proteins and conjugates that contain at least a portion of a heat shock protein; response detected by measuring interferon (ifn)-gamma produced by the cell sample
12/17/2002	US6495346 Do not react with foreign partners; amino acids inserted into proteins which naturally form dimers, mutated proteins only form complexes with themselves (homodimers) or with the mutated partner (heterodimers), not with nonmutated starting
12/17/2002	US6495345 Surface antigen
12/17/2002	US6495343 Cloning and recombinant production of CRF receptor(s)
12/17/2002	US6495339 Method of identifying a compound that modulates XAF-mediated apoptosis
12/17/2002	US6495332 Methods and compositions for ameliorating the symptoms of sepsis
12/17/2002	US6495321 Randomisation of the entire gene sequence in combination with the selection of a variant (mutant) protein with the desired characteristics, followed by a new round of random mutagenesis and selection
12/17/2002	US6495128 Human chemokine β-7 deletion and substitution proteins
12/17/2002	CA2214439C A novel growth factor and a genetic sequence encoding same
12/17/2002	CA2080260C Monoclonal antibodies against tumor-associated antigens, processes for the preparation thereof and the use thereof
12/17/2002	CA1341411C Method for producing fv fragments in eukaryotic cells
12/17/2002	CA1341410C Recombinant acquired immune deficiency syndrome (aids) viral envelope protein and method of testing for aids
12/17/2002	CA1341409C Cloning and expression of htlv-iii dna
12/12/2002	WO2002099382A2 Multiplexing method
12/12/2002	WO2002099115A2 Nucleic acid-associated proteins
12/12/2002	WO2002099108A2 Atp-binding cassette transporter-like molecules and uses thereof
12/12/2002	WO2002099100A2 Method of production of a protein in cells which inducibly express the cell cycle inhibitor protein, p21

1 ... 624 625 626 627 628 629 630 631 632 633 634 635 636 637 638 639 640 641 642 643 644 ... 1125